Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
Hemasphere|February 26, 2026
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working PartyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Bone Marrow Transplantation|February 22, 2018
Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow TransplantationIrit Avivi, Ariane Boumendil, Hervé Finel, et al.
Blood|December 14, 2011
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party studyJan Styczynski, Adriana Balduzzi, Lidia Gil, et al.
Blood Advances|August 26, 2018
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP studySalyka Sengsayadeth, Katie S Gatwood, Ariane Boumendil, et al.
Bone Marrow Transplantation|July 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Ryszard Swoboda, et al.
Transplantation and Cellular Therapy|December 28, 2022
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for LymphomasAlberto Mussetti, Abraham S Kanate, Tao Wang, et al.
Nature Medicine|January 17, 2024
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphomaFrederick L Locke, Simone Filosto, Justin Chou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR ReportFiroozeh Sahebi, Laurent Garderet, Abraham S Kanate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)Nicolaus Kröger, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Pageof 32